All Stories

  1. Population-based service mammography screening: the Icelandic experience

    Article • Breast Cancer Targets and Therapy, May 2013, Taylor & Francis

    MD, PhD kristjan sigurdsson

  2. The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials

    Article • International Journal of Cancer, January 2011, Wiley

    MD, PhD kristjan sigurdsson

  3. HPV 16/18 vaccines and the impact on organized cervical cancer screening

    Article • Acta Obstetricia Et Gynecologica Scandinavica, June 2010, Wiley

    MD, PhD kristjan sigurdsson, Paolo Giorgi Rossi

  4. The efficacy of HPV 16/18 vaccines on sexually active 18–23 year old women and the impact of HPV vaccination on organized cervical cancer screening

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2009, Wiley

    MD, PhD kristjan sigurdsson

  5. Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in preinvasive and invasive diseases

    Article • European Journal of Cancer, March 2007, Elsevier

    MD, PhD kristjan sigurdsson

  6. HPV genotypes in CIN 2-3 lesions and cervical cancer: A population-based study

    Article • International Journal of Cancer, January 2007, Wiley

    MD, PhD kristjan sigurdsson

  7. Effectiveness of Cervical Cancer Screening in Iceland, 1964???2002: A Study on Trends in Incidence and Mortality and the Effect of Risk Factors

    Article • Obstetrical & Gynecological Survey, July 2006, Wolters Kluwer Health

    MD, PhD kristjan sigurdsson

  8. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2006, Wiley

    MD, PhD kristjan sigurdsson

  9. Longitudinal trends in cervical histological lesions (CIN 2–3 + ): A 25-year overview

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2006, Wiley

    MD, PhD kristjan sigurdsson

  10. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2006, Wiley

    MD, PhD kristjan sigurdsson

  11. Effectiveness of cervical cancer screening in Iceland, 1964–2002: a study on trends in incidence and mortality and the effect of risk factors

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2006, Wiley

    MD, PhD kristjan sigurdsson

  12. HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958–1960 and 1995–1996☆

    Article • Gynecologic Oncology, April 2003, Elsevier

    MD, PhD kristjan sigurdsson

  13. Risk variables affecting high-grade pap smears at second visit: Effects of screening interval, year, age and low-grade smears

    Article • International Journal of Cancer, January 2001, Wiley

    MD, PhD kristjan sigurdsson

  14. The Icelandic and Nordic cervical screening programs, Trends in incidence and mortality rates through 1995

    Article • Acta Obstetricia Et Gynecologica Scandinavica, June 1999, Wiley

    MD, PhD kristjan sigurdsson

  15. Trends in cervical intra-epithelial neoplasia in Iceland through 1995, Evaluation of targeted age groups and screening intervals

    Article • Acta Obstetricia Et Gynecologica Scandinavica, June 1999, Wiley

    MD, PhD kristjan sigurdsson

  16. Cervical cancer, Pap smear and HPV testing, An update of the role of organized Pap smear screening and HPV testing

    Article • Acta Obstetricia Et Gynecologica Scandinavica, June 1999, Wiley

    MD, PhD kristjan sigurdsson

  17. The Icelandic and Nordic cervical screening programs, Trends in incidence and mortality rates through 1995

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1999, Wiley

    MD, PhD kristjan sigurdsson

  18. Trends in cervical intra-epithelial neoplasia in Iceland through 1995, Evaluation of targeted age groups and screening intervals

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1999, Wiley

    MD, PhD kristjan sigurdsson

  19. Cervical cancer, Pap smear and HPV testing, An update of the role of organized Pap smear screening and HPV testing

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1999, Wiley

    MD, PhD kristjan sigurdsson

  20. Survival and prognostic factors of endometrial cancer patients in Iceland 1964–1985: Can attendance at population-based pap-smear screening affect survival?

    Article • International Journal of Cancer, April 1998, Wiley

    MD, PhD kristjan sigurdsson

  21. Human papillomavirus (HPV) in an Icelandic population: The role of HPV DNA testing based on hybrid capture and PCR assays among women with screen‐detected abnormal pap smears

    Article • International Journal of Cancer, July 1997, Wiley

    MD, PhD kristjan sigurdsson

  22. Human papillomavirus (HPV) in an Icelandic population: The role of HPV DNA testing based on hybrid capture and PCR assays among women with screen-detected abnormal pap smears

    Article • International Journal of Cancer, July 1997, Wiley

    MD, PhD kristjan sigurdsson

  23. What attendance rate can be achieved for Pap smear screening?: A case-control study of the characteristics of non-attenders and results of reminder efforts

    Article • Scandinavian Journal of Primary Health Care, January 1996, Taylor & Francis

    MD, PhD kristjan sigurdsson

  24. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in iceland, 1964–1991

    Article • International Journal of Cancer, June 1993, Wiley

    MD, PhD kristjan sigurdsson

  25. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955–1989, their relation to screening and prediction to the year 2000

    Article • International Journal of Cancer, June 1991, Wiley

    MD, PhD kristjan sigurdsson

  26. Reproductive factors and breast cancer risk in Iceland. A second cohort study

    Article • International Journal of Cancer, December 1990, Wiley

    MD, PhD kristjan sigurdsson

  27. The value of screening as an approach to cervical cancer control in iceland, 1964-1986

    Article • International Journal of Cancer, January 1989, Wiley

    MD, PhD kristjan sigurdsson

  28. Advanced Stage III Ovarian Carcinoma: Prospective Randomized Trials Comparing Radiotherapy and Chemotherapy

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1986, Wiley

    MD, PhD kristjan sigurdsson

  29. Prognostic factors in malignant epithelial ovarian tumors

    Article • Gynecologic Oncology, June 1983, Elsevier

    MD, PhD kristjan sigurdsson

  30. Bleomycin-mitomycin C in advanced carcinoma of the cervix: A third look

    Article • Cancer, February 1983, Wiley

    MD, PhD kristjan sigurdsson

  31. Tranexamic Acid for the Treatment of Advanced Ovarian Carcinoma

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1983, Wiley

    MD, PhD kristjan sigurdsson